Create
Learn
Share

Mabs

rename
wepusuda's version from 2016-05-15 20:50

Section

Question Answer
LebrikizumabIL-13,
DupilumabIL-4 receptor (IL-4Ra); blocks signalling via IL-4 and IL-13Rs
MepolizumabIL-5, Exacerbations often require systemic steroid treatment, which has serious side effects > blocking IL-5 can prevent this
BenralizumabIL-5R. Causes depletion of eosinophils for months after a single injection
memorize